Why this changes a decision
Cost recovery and funding strategy are related, but they are not the same decision. One asks what an eligible award can reimburse. The other asks whether the organization should deepen, diversify, or redesign a funding position after cash timing, restrictions, capability, evidence, and dependency are read together.
Fact one: de minimis recovery increased for eligible entities
OMB’s 2024 Uniform Guidance permits a recipient or subrecipient without a current negotiated indirect-cost rate to elect up to 15% of MTDC, compared with the prior 10% ceiling. That is a 5-percentage-point change in the rate, or a 50% increase in the ceiling itself. It applies through the de minimis path, subject to statute, regulation, agency implementation, and award terms. Evidence vintage: final guidance published April 22, 2024; effective October 1, 2024; reviewed August 3, 2026.
Fact two: large-scale nonprofits often built around a dominant revenue category
Bridgespan studied 297 U.S. nonprofits founded since 1990 that had reached at least $50 million in annual revenue within roughly 30 years. More than 90% had a dominant revenue category. About 80% of the financial records used were from 2021, with the remainder from 2020 or 2022. Evidence vintage: Bridgespan study published June 20, 2024; reviewed August 3, 2026.
The connection
A dominant category can represent accumulated capability: relationships, systems, compliance knowledge, and a delivery model built for that source. It can also create dependency. The Bridgespan finding does not tell a particular organization which condition it has, and it does not establish that any organization in the study used the de minimis rate.
The regulatory change therefore belongs inside an award-and-portfolio model, not inside a slogan about concentration. A higher indirect ceiling can improve the economics of an eligible pursuit while the same award still worsens cash exposure, adds conflicting restrictions, or deepens reliance on one payer. It can also strengthen a well-chosen specialty. The record decides which.
What this changes
Test the actual recovery difference on the eligible MTDC base, then place that result beside payment timing, match, reporting labor, restrictions, renewal exposure, and the rest of the funding mix. Ask whether the award uses an existing organizational capability, builds a reusable one, or consumes capacity needed for a stronger move. Only then decide whether it diversifies the portfolio, deepens a productive position, or increases dependency.
What the evidence does not say
Bridgespan’s sample is specific: relatively young U.S. nonprofits that reached at least $50 million in annual revenue. It is not a benchmark for every nonprofit, a causal finding that concentration produces scale, or evidence that the organizations were eligible for de minimis recovery. The 15% rate is not available to an entity with a current negotiated indirect-cost rate and may be displaced by a statutory or regulatory exception. NIH is one current example.